EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Leserbrief

Phase II trial of posaconazole prophylaxis during anti‐thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome

Dong Hyun Kim iD, Junshik Hong iD, Dong-Yeop Shin iD, Inho Kim iD, Sung-Soo Yoon iD, Soo Mee Bang, Jeong-Ok Lee, Ji Yun Lee, Sang-A Kim iD, Ja Min Byun iD, Youngil Koh iD

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19500 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Dong Hyun Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. Hauptthemen laut MEDLINE: Antilymphocyte Serum, Anemia, Aplastic, Triazoles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antilymphocyte SerumAnemia, AplasticTriazolesHumansMaleFemaleMyelodysplastic SyndromesAdultMiddle AgedAntifungal AgentsAged

Substanzen

Antilymphocyte SerumposaconazoleTriazolesAntifungal Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
  • Center for Medical Innovation, Seoul National University Hospital, Seoul, Korea.
  • Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul, Korea.

ORCID-Profile: Dong Hyun Kim, Junshik Hong, Dong-Yeop Shin, Inho Kim, Sung-Soo Yoon, Sang-A Kim, Ja Min Byun, Youngil Koh

Zitieren

APA

Kim, D. H., Hong, J., Shin, D. Y., Kim, I., Yoon, S. S., Bang, S. M., Lee, J. O., Lee, J. Y., Kim, S. A., Byun, J. M., & Koh, Y. (2024). Phase II trial of posaconazole prophylaxis during anti‐thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome. British Journal of Haematology. https://doi.org/10.1111/bjh.19500

Vancouver

Kim DH, Hong J, Shin DY, Kim I, Yoon SS, Bang SM, et al. Phase II trial of posaconazole prophylaxis during anti‐thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome. British Journal of Haematology. 2024. doi:10.1111/bjh.19500

BibTeX
@article{Kim2024,
  author = {Kim, Dong Hyun and Hong, Junshik and Shin, Dong-Yeop and Kim, Inho and Yoon, Sung-Soo and Bang, Soo Mee and Lee, Jeong-Ok and Lee, Ji Yun and Kim, Sang-A and Byun, Ja Min and Koh, Youngil},
  title = {Phase II trial of posaconazole prophylaxis during anti‐thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19500}
}
Kostenlos starten →